UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 22.

Schrappe, M; Niggli, F; et al (2013). Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000. Klinische Pädiatrie, 225 Supp:S62-S72.

Möricke, A; Lauten, M; Beier, R; Odenwald, E; Stanulla, M; Zimmermann, M; Attarbaschi, A; Niggli, F; Schrappe, M (2013). Prediction of outcome by early response in childhood acute lymphoblastic leukemia. Klinische Pädiatrie, 225 Supp:S50-S56.

Grouls, S; Iglesias, D M; Wentzensen, N; Moeller, M J; Bouchard, M; Kemler, R; Goodyer, P; Niggli, F; Gröne, H J; Kriz, W; Koesters, R (2012). Lineage specification of parietal epithelial cells requires β-Catenin/Wnt signaling. Journal of the American Society of Nephrology (JASN), 23(1):63-72.

Paulides, M; Stöhr, W; Laws, H J; Graf, N; Lakomek, M; Berthold, F; Schmitt, K; Niggli, F; Jürgens, H; Bielack, S; Koscielniak, E; Klingebiel, T; Langer, T (2011). Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System. Vaccine, 29(8):1565-1568.

Niggli, F; Lamontagne-Müller, I (2011). Krebsforschung in der Schweiz aus Sicht der Kinder-Onkologie. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 31(2):116-117.

Burkhardt, B; Oschlies, I; Klapper, W; Zimmermann, M; Woessmann, W; Meinhardt, A; Landmann, E; Attarbaschi, A; Niggli, F; Schrappe, M; Reiter, A (2011). Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia, 25(1):153-160.

Feller, M; Adam, M; Zwahlen, M; Brazzola, P; Niggli, F; Kuehni, C (2010). Family characteristics as risk factors for childhood acute lymphoblastic leukemia: a population-based case-control study. PLoS ONE, 5(10):e13156.

Adam, M; von der Weid, N; Michel, G; Zwahlen, M; Lutz, J M; Probst-Hensch, N; Niggli, F; Kuehni, C (2010). Access to specialized pediatric cancer care in Switzerland. Pediatric Blood & Cancer, 54(5):721-727.

Paulides, M; Stöhr, W; Laws, H J; Graf, N; Lakomek, M; Berthold, F; Schmitt, K; Niggli, F; Jürgens, H; Bielack, S; Koscielniak, E; Klingebiel, T; Langer, T (2010). Immunity against tetanus and diphtheria after childhood sarcoma treatment. Klinische Pädiatrie, 222(3):196.

Tallen, G; Ratei, R; Mann, G; Kaspers, G; Niggli, F; Karachunsky, A; Ebell, W; Escherich, G; Schrappe, M; Klingebiel, T; Fengler, R; Henze, G; von Stackelberg, A (2010). Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. Journal of Clinical Oncology, 28(14):2339-2347.

Möricke, A; Zimmermann, M; Reiter, A; Henze, G; Schrauder, A; Gadner, H; Ludwig, W D; Ritter, J; Harbott, J; Mann, G; Klingebiel, T; Zintl, F; Niemeyer, C; Kremens, B; Niggli, F; Niethammer, D; Welte, K; Stanulla, M; Odenwald, E; Riehm, H; Schrappe, M (2010). Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24(2):265-284.

Conter, V; Bartram, C R; Valsecchi, M G; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Aricò, M; Zimmermann, M; Mann, G; De Rossi, G; Stanulla, M; Locatelli, F; Basso, G; Niggli, F; Barisone, E; Henze, G; Ludwig, W D; Haas, O A; Cazzaniga, G; Koehler, R; Silvestri, D; Bradtke, J; Parasole, R; Beier, R; van Dongen, J J M; Biondi, A; Schrappe, M (2010). Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115(16):3206-14.

Schäfer, B W; Niggli, F (2010). Multidisciplinary management of childhood sarcoma: time to expand. Expert Review of Anticancer Therapy, 10(8):1163-1166.

Ehrlich, D; Bruder, E; Thome, M; Gutt, C; von Knebel Doeberitz, M; Niggli, F; Perantoni, A; Bode, M; Koesters, R (2010). Nuclear accumulation of beta-Catenin protein indicates frequent activation of Wnt-signaling in chemically-induced rat nephroblastomas. Pediatric and Developmental Pathology, 13(1):1-8.

Pichler, H; Möricke, A; Mann, G; Teigler-Schlegel, A; Niggli, F; Nebral, K; König, M; Inthal, A; Krehan, D; Dworzak, M N; Janousek, D; Harbott, J; Schrappe, M; Gadner, H; Strehl, S; Haas, O A; Panzer-Grümayer, R; Attarbaschi, A (2010). Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. British Journal of Haematology, 149(1):93-100.

Güngör, T; Scherer, F; Molinari, L; Schmugge, M; Bourquin, J P; Niggli, F; Seger, R (2009). Überlebensrate und Mortalität nach allogener und autologer hämatopoietischer Stammzelltransplantation (HSZT) an den Universitäts-Kinderkliniken Zürich: eine vergleichende Analyse von 1991 bis 2006. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 29(1):41-44.

Theissen, J; Boensch, M; Spitz, R; Betts, D; Stegmaier, S; Christiansen, H; Niggli, F; Schilling, F; Schwab, M; Simon, T; Westermann, F; Berthold, F; Hero, B (2009). Heterogeneity of the MYCN oncogene in neuroblastoma. Clinical Cancer Research, 15(6):2085-2090.

Bodmer, N; Niggli, F (2009). Knochen- und Weichteilsarkome im Jugendalter. Schweizer Zeitschrift für Onkologie, 2009(4):14-17.

Niggli, F (2009). Tumoren im Kindesalter: Herausforderungen der heutigen Kinderonkologie. Schweizer Zeitschrift für Onkologie:4.

Dantonello, T M; Int-Veen, C; Winkler, P; Leuschner, I; Schuck, A; Schmidt, B F; Lochbuehler, H; Kirsch, S; Hallmen, E; Veit-Friedrich, I; Bielack, S S; Niggli, F; Kazanowska, B; Ladenstein, R; Wiebe, T; Klingebiel, T; Treuner, J; Koscielniak, E (2008). Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. Journal of Clinical Oncology, 26(3):406-413.

Reinhard, H; Schmidt, A; Furtwängler, R; Leuschner, I; Rübe, C; Von Schweinitz, D; Zoubek, A; Niggli, F; Graf, N (2008). Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies. Oncology Reports, 20(2):463-467.

Möricke, A; Reiter, A; Zimmermann, M; Gadner, H; Stanulla, M; Dördelmann, N; Löning, L; Beier, R; Ludwig, W D; Ratei, R; Harbott, J; Boos, H; Mann, G; Niggli, F; Feldges, A; Henze, G; Welte, K; Beck, J D; Klingebiel, T; Niemeyer, C; Zintl, F; Bode, U; Urban, C; Wehinger, H; Niethammer, D; Riehm, H; Schrappe, M (2008). Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111(9):4477-4489.

This list was generated on Sat Jul 22 12:03:38 2017 CEST.